Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Spanjaart A. M.;Ljungman P.;de La Camara R.;Tridello G.;Ortiz-Maldonado V.;Urbano-Ispizua A.;Barba P.;Kwon M.;Caballero D.;Sesques P.;Bachy E.;Di Blasi R.;Thieblemont C.;Calkoen F.;Mutsaers P.;Maertens J.;Giannoni L.;Nicholson E.;Collin M.;Vaz C. P.;Metafuni E.;Martinez-Lopez J.;Dignan F. L.;Ribera J. -M.;Nagler A.;Folber F.;Sanderson R.;Bloor A.;Ciceri F.;Knelange N.;Ayuk F.;Kroger N.;Kersten M. J.;Mielke S.

2021-01-01